BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gómez-Outes A, Suárez-Gea ML, García-Pinilla JM. Causes of death in atrial fibrillation: Challenges and opportunities. Trends Cardiovasc Med 2017;27:494-503. [PMID: 28602539 DOI: 10.1016/j.tcm.2017.05.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bencivenga L, Komici K, Nocella P, Grieco FV, Spezzano A, Puzone B, Cannavo A, Cittadini A, Corbi G, Ferrara N, Rengo G. Atrial fibrillation in the elderly: a risk factor beyond stroke. Ageing Research Reviews 2020;61:101092. [DOI: 10.1016/j.arr.2020.101092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Huikuri HV. Editorial Commentary: Atrial fibrillation: Challenges and opportunities. Trends Cardiovasc Med 2017;27:504-5. [PMID: 28623083 DOI: 10.1016/j.tcm.2017.05.007] [Reference Citation Analysis]
3 Deyranlou A, Miller CA, Revell A, Keshmiri A. Effects of Ageing on Aortic Circulation During Atrial Fibrillation; a Numerical Study on Different Aortic Morphologies. Ann Biomed Eng 2021. [PMID: 33655419 DOI: 10.1007/s10439-021-02744-9] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Liu Y, Chen J, Bao N, Gupta BB, Lv Z. Survey on atrial fibrillation detection from a single-lead ECG wave for Internet of Medical Things. Computer Communications 2021;178:245-58. [DOI: 10.1016/j.comcom.2021.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
5 Gómez-Outes A, Suárez-Gea ML, García-Pinilla JM. When are the cardiovascular and stroke risks too high? Pharmacotherapy for stroke prophylaxis. Expert Opin Pharmacother 2018;19:1427-40. [PMID: 30198347 DOI: 10.1080/14656566.2018.1511703] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Kichloo A, Dahiya DS, Shaka H, Jamal S, Khan MZ, Wani F, Mehboob A, Kanjwal K. Impact of atrial fibrillation on inflammatory bowel disease hospitalizations-a nationwide retrospective study. Proc (Bayl Univ Med Cent) 2021;34:673-7. [PMID: 34732983 DOI: 10.1080/08998280.2021.1951071] [Reference Citation Analysis]
7 Hu WS, Lin CL. Comparisons of HATCH, HAVOC and CHA2DS2-VASc scores for all-cause mortality prediction in atrial fibrillation: a real-world evidence study. Postgrad Med J 2022:postgradmedj-2021-141147. [PMID: 35074802 DOI: 10.1136/postgradmedj-2021-141147] [Reference Citation Analysis]
8 Deyranlou A, Naish JH, Miller CA, Revell A, Keshmiri A. Numerical Study of Atrial Fibrillation Effects on Flow Distribution in Aortic Circulation. Ann Biomed Eng 2020;48:1291-308. [PMID: 31938982 DOI: 10.1007/s10439-020-02448-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
9 Corrado D, Zorzi A. Risk of Catheter Ablation for Atrial Fibrillation. JACC Clin Electrophysiol 2017;3:1434-6. [PMID: 29759675 DOI: 10.1016/j.jacep.2017.07.002] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Shah SR, Luu SW, Calestino M, David J, Christopher B. Management of atrial fibrillation-flutter: uptodate guideline paper on the current evidence. J Community Hosp Intern Med Perspect 2018;8:269-75. [PMID: 30357020 DOI: 10.1080/20009666.2018.1514932] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Xu W, Yang YM, Zhu J, Wu S, Wang J, Zhang H, Shao XH. Impact of renin-angiotensin-aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension. BMC Cardiovasc Disord 2022;22:141. [PMID: 35365067 DOI: 10.1186/s12872-022-02580-2] [Reference Citation Analysis]